Olema Oncology

formerly Olema PharmaceuticalsIPO

Olema Oncology is a biotech company in San Francisco, United States, founded in 2006. It has raised $142.0M across 3 rounds, most recently an $85.0M Series C in October 2020.

Developing better medicines for breast cancer and beyond

Employees
51–200
Founded
2006
Business Model
B2B
Website
olema.com
Total Funding
$142.0M
Last Round
$85.0M Series COct 2020
Rounds
3
Type
Public

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 3 funding rounds and 1 investor for this company. The full record is or through the API.

About

Olema Oncology is a clinical-stage biopharmaceutical company focused on transforming the treatment paradigm for metastatic breast cancer and endocrine-driven cancers. The company's lead program, palazestrant (OP-1250), is a differentiated oral complete estrogen receptor antagonist (CERAN) in late-stage clinical development; its pipeline also includes OP-3136, a potent oral KAT6 inhibitor. Founded in 2006 and headquartered in San Francisco with operations in Cambridge, Massachusetts, Olema is a publicly traded company (Nasdaq) advancing multiple clinical trials for patients with ER+/HER2- metastatic breast cancer and other solid tumors.

Summary

It lists 51–200 employees. It has raised $142.0M in total across 3 rounds, most recently a $85.0M Series C round in Oct 2020. Investors include BVF Partners.

Tech & App Stack

7 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

Data from Indexed.vcUpdated
Secondary MarketSecondary MarketSep 2023

Sign up to see all 6 events

Funding: Series B through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Olema Oncology on Indexed.vc
<a href="https://indexed.vc/companies/olema-oncology"><img src="https://indexed.vc/api/badge/company/olema-oncology" alt="Olema Oncology on Indexed.vc" width="260" height="76" /></a>